A61K38/011

COMBINATION OF LACTOBACILLI FOR THE RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR THE RELIEF OF OTHER GASTROINTESTINAL DISORDERS
20210401905 · 2021-12-30 · ·

Described herein are compositions and methods relating to the use of a combination of live lactobacilli bacteria, particularly live Lactobacillus acidophilus, live Lactobacillus casei, and live Lactobacillus rhamnosus, for the relief of undesirable gastromtestmal health problems such as irritable bowel syndrome (IBS), abdominal pain, abdominal discomfort, bloating, liquid stools and constipation. This combination of live lactobacilli bacteria can also be used for improving quality of life of a subject suffering from IBS, for the relief of IBS, and/or for the prevention and/or treatment of IBS.

Composition and method for germinative compounds in probiotic food and beverage products for human consumption

A composition and method for activating probiotic spores in food and beverage products, such as steeped teas, coffee, soups, and sauces. A nutrient-germinant composition comprises one or more L-amino acids, optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8, optionally D-glucose, D-fructose, or both D-glucose and D-fructose, and optionally, an osmoprotectant. The nutrient-germinant composition, one or more species of Bacillus spores, and a food or beverage product may be pre-mixed in any combination. Water is added to the mixture and heated to a temperature range of 42 to 100° C. to germinate the probiotic spores prior to being consumed.

ORONASAL CBD FORMULATIONS AND USES THEREOF
20210393576 · 2021-12-23 ·

Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.

ORONASAL CBD FORMULATIONS AND USES THEREOF
20210393576 · 2021-12-23 ·

Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.

NUTRITION-BASED SUPPORT FOR THE BODY'S OWN WOUND HEALING PROCESSES
20210369772 · 2021-12-02 · ·

The use of a preparation for nutrition-based support of the body's own wound healing processes at the local and systemic level by oral intake of the preparation, which contains per gram as a basic preparation the following mixture of vitamins and nutrients: a. 330-385 μg of vitamin B1, b. 420-490 μg of vitamin B2, c. 4.8-5.6 mg of vitamin B3, d. 1.8-2.1 mg of vitamin B5, e. 420-490 μg of vitamin B6, f. 15-18 μg of vitamin H, g. 80-390 μg of vitamin B9, h. 1.0-4.9 μg of vitamin B12, i. 32-156 mg of vitamin C, j. 150-731 mg of magnesium, k. 4-20 mg of zinc and l. 3-200 mg of tryptophan.

NUTRITION-BASED SUPPORT FOR THE BODY'S OWN WOUND HEALING PROCESSES
20210369772 · 2021-12-02 · ·

The use of a preparation for nutrition-based support of the body's own wound healing processes at the local and systemic level by oral intake of the preparation, which contains per gram as a basic preparation the following mixture of vitamins and nutrients: a. 330-385 μg of vitamin B1, b. 420-490 μg of vitamin B2, c. 4.8-5.6 mg of vitamin B3, d. 1.8-2.1 mg of vitamin B5, e. 420-490 μg of vitamin B6, f. 15-18 μg of vitamin H, g. 80-390 μg of vitamin B9, h. 1.0-4.9 μg of vitamin B12, i. 32-156 mg of vitamin C, j. 150-731 mg of magnesium, k. 4-20 mg of zinc and l. 3-200 mg of tryptophan.

USE OF CYCLO(HIS-PRO) (CHP) FOR PREVENTING, ALLEVIATING OR TREATING PERITONEAL FIBROSIS

A cyclo(His-Pro)(CHP) is useful for preventing, alleviating or treating peritoneal fibrosis. A pharmaceutical composition for preventing or treating peritoneal fibrosis, a dietary supplement composition for preventing or alleviating peritoneal fibrosis, and a peritoneal dialysis solution, which all contain CHP is disclosed. Also disclosed are a method for preventing or treating peritoneal fibrosis by using CHP, a peritoneal dialysis method using CHP, a use of CHP during the preparation of a pharmaceutical composition for preventing or treating peritoneal fibrosis, and/or a use of CHP in the preparation of a peritoneal dialysis solution.

PREOPERATIVE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
20220193156 · 2022-06-23 ·

Disclosed are preoperative compositions and methods of preparation thereof. The preoperative compositions may be for minimizing thirst, vomiting, insulin resistance, and the like prior to surgery. Such preoperative compositions may also reduce postoperative complications and the need for pain relievers, as well as minimize blood transfusion needed during and after surgery when administered the night before the operation and/or an hour before the operation. The preoperative compositions may include soymilk, isolate milk protein, isolate pea proteins, probiotics, whole milk powder, and micronutrients for example.

PREOPERATIVE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
20220193156 · 2022-06-23 ·

Disclosed are preoperative compositions and methods of preparation thereof. The preoperative compositions may be for minimizing thirst, vomiting, insulin resistance, and the like prior to surgery. Such preoperative compositions may also reduce postoperative complications and the need for pain relievers, as well as minimize blood transfusion needed during and after surgery when administered the night before the operation and/or an hour before the operation. The preoperative compositions may include soymilk, isolate milk protein, isolate pea proteins, probiotics, whole milk powder, and micronutrients for example.

Sunflower seed protein-derived peptides

A protein hydrolysate composition is provided. The protein hydrolysate composition comprises isolated peptides useful for ameliorating a condition of a subject. Compositions comprising the protein hydrolysate composition are also provided. The compositions may be adapted for oral or topical administration to the subject, and may compose a foodstuff or beverage (e.g. a medical food), a topical composition (e.g. a lotion, cream, etc.), a kit, and the like. A methods of ameliorating the condition of the subject is further provided. The method include administering the protein hydrolysate composition to the subject. The method may be useful in reducing blood pressure, inflammation, reduced immunity, and/or oxidative stress in the subject.